<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Dominguez-Berzosa L</submitter><funding>Instituto de Salud Carlos III</funding><funding>Ministerio de Ciencia, Innovación y Universidades</funding><pagination>10705</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11477271</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25(19)</volume><pubmed_abstract>The &lt;i>Taq&lt;/i>IA polymorphism is a marker of both the Ankyrin Repeat and Kinase Domain containing I gene (&lt;i>ANKK1&lt;/i>) encoding a RIP-kinase, and the &lt;i>DRD2&lt;/i> gene for the dopamine receptor D2. Despite a large number of studies of &lt;i>Taq&lt;/i>IA in addictions and other psychiatric disorders, there is difficulty in interpreting this genetic phenomenon due to the lack of knowledge about ANKK1 function. In SH-SY5Y neuroblastoma models, we show that ANKK1 interacts with the synapse protein FERM ARH/RhoGEF and Pleckstrin Domain 1 (FARP1), which is a guanine nucleotide exchange factor (GEF) of the RhoGTPases RAC1 and RhoA. ANKK1-FARP1 colocalized in F-ACTIN-rich structures for neuronal maturation and migration, and both proteins activate the Wnt/PCP pathway. ANKK1, but not FARP1, promotes neur</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>ANKK1 Is a Wnt/PCP Scaffold Protein for Neural F-ACTIN Assembly.</pubmed_title><pmcid>PMC11477271</pmcid><funding_grant_id>PI22/00680</funding_grant_id><funding_grant_id>CEX2020-001041-S</funding_grant_id><funding_grant_id>PI19/00126</funding_grant_id><pubmed_authors>Hoenicka J</pubmed_authors><pubmed_authors>Lopez JA</pubmed_authors><pubmed_authors>Tort G</pubmed_authors><pubmed_authors>Garrido E</pubmed_authors><pubmed_authors>Palau F</pubmed_authors><pubmed_authors>Rodriguez-Sanz M</pubmed_authors><pubmed_authors>Urquizu E</pubmed_authors><pubmed_authors>Cantarero L</pubmed_authors><pubmed_authors>Dominguez-Berzosa L</pubmed_authors><pubmed_authors>Saez M</pubmed_authors><pubmed_authors>Fernandez-Lizarbe S</pubmed_authors><pubmed_authors>Castro-Martinez XH</pubmed_authors><pubmed_authors>Calvo E</pubmed_authors><pubmed_authors>Troya-Balseca J</pubmed_authors><pubmed_authors>Palomo T</pubmed_authors></additional><is_claimable>false</is_claimable><name>ANKK1 Is a Wnt/PCP Scaffold Protein for Neural F-ACTIN Assembly.</name><description>The &lt;i>Taq&lt;/i>IA polymorphism is a marker of both the Ankyrin Repeat and Kinase Domain containing I gene (&lt;i>ANKK1&lt;/i>) encoding a RIP-kinase, and the &lt;i>DRD2&lt;/i> gene for the dopamine receptor D2. Despite a large number of studies of &lt;i>Taq&lt;/i>IA in addictions and other psychiatric disorders, there is difficulty in interpreting this genetic phenomenon due to the lack of knowledge about ANKK1 function. In SH-SY5Y neuroblastoma models, we show that ANKK1 interacts with the synapse protein FERM ARH/RhoGEF and Pleckstrin Domain 1 (FARP1), which is a guanine nucleotide exchange factor (GEF) of the RhoGTPases RAC1 and RhoA. ANKK1-FARP1 colocalized in F-ACTIN-rich structures for neuronal maturation and migration, and both proteins activate the Wnt/PCP pathway. ANKK1, but not FARP1, promotes neur</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2026-07-05T03:16:49.269Z</modification><creation>2025-04-04T23:50:12.326Z</creation></dates><accession>S-EPMC11477271</accession><cross_references><pubmed>39409035</pubmed><doi>10.3390/ijms251910705</doi></cross_references></HashMap>